Gemcitabine derivatives nanoparticles
US7704972B2 · kind B2 · utility
8Cited by
2References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 23, 2005 |
| Grant date | Apr 27, 2010 |
| Priority date | — |
| Expiry date | Jan 23, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a 2′,2′-difluoro-2′-deoxycytidine derivative of general formula (I), wherein: R1, R2 and R3, identical or different, represent independently of one another, a hydrogen atom or an at least C18 hydrocarbon acyl radical and of such conformation that it is capable of providing the compound of general formula (I), a compacted form in a polar solvent medium, at least one of groups R1, R2 and R3 being other than a hydrogen atom.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.